RDM1 is linked to poor prognosis in hepatocellular carcinoma (HCC) chemotherapy. We investigated its post-transcriptional regulation and developed a targeted co-delivery strategy to enhance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results